In the reference list of this article, reference 7 was incorrect and is replaced as follows:
7. Buse JB, Garg SK, Rosenstock J, et al. Sotagliflozin in combination with optimized insulin therapy in adults with type 1 diabetes: the North American inTandem1 study. Diabetes Care 2018;41:1970–1980
In addition, in Table 1 the incidence rates in the placebo arm (IRPlb) and change in absolute risk (ΔIR) presented for the LEADER trial have been corrected, and Figure 2 has been revised using the corrected data.
The authors apologize for the errors. The online version of the article (https://doi.org/10.2337/dc20-0913) has been corrected to include the new reference and the revised figure and table.
© 2021 by the American Diabetes Association
2021
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
